Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.
about
Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean populationNeuroimaging of Parkinson's disease: Expanding views.Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.Neuroimaging in Parkinson disease: from research setting to clinical practice.Neuroimaging in pre-motor Parkinson's disease(123)I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component.Transcranial sonography findings related to depression in parkinsonian disorders: cross-sectional study in 126 patients.T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.The differentiation of progressive supranuclear palsy.Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity.Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort.Retrospective Diagnosis of Parkinsonian Syndromes Using Whole-Brain Atrophy Rates.Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study.Prediction of Neurocognitive Deficits by Parkinsonian Motor Impairment in Schizophrenia: A Study in Neuroleptic-Naïve Subjects, Unaffected First-Degree Relatives and Healthy Controls From an Indigenous Population.Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.Transcranial Ultrasonographic Image Analysis System for Decision Support in Parkinson Disease.Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.Transcranial sonography in idiopathic REM sleep behavior disorder and multiple system atrophy.A population-based study on combined markers for early Parkinson's disease.New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson's Disease.Biomarkers for Parkinson's Disease: Recent Advancement.The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease.DaTscan and Parkinson's disease: DAT binding should not lead to binding decisions in clinical practice.[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.Recent Advances in Biomarkers for Parkinson's Disease
P2860
Q27303919-5143B4FA-8A37-4332-84D5-6E5751CEA3BAQ28387732-080BAECD-E27B-4B54-8D6E-56E7002F51C4Q30373174-941B8A61-E79B-4D07-9E35-CB97A7D152F0Q30868628-F618056D-70BE-4081-8186-A7A5AF2A72F3Q33676222-B43DAE35-3BF3-4100-8359-45D2944A12C1Q35802554-113EE499-5B9B-46E7-9BF4-C692FF7DA161Q36930590-796827C7-EF97-40F7-8BD7-BAAFC8DADB07Q37396921-7753E098-F6E9-4DD5-A6E9-CD7E9769D2C8Q38618462-4D799D3A-2E28-4687-87B7-AF2399F5DD07Q38645895-00F84D8B-BE62-4A51-AC42-E6D6613E584FQ40294867-D67521C2-FD7F-42A7-AC5B-F124292AE9A4Q42291087-74D1CB6D-81ED-492E-BF89-371A8B9A3E46Q42544369-6EF2B9A8-FA0F-4DFC-8D33-E705AF4DAB9EQ42650152-6D840BBD-CED7-4427-B3EA-8299294E2F7BQ44233511-2D8C52EE-E494-4D7D-A602-12BB7FF549ECQ47563941-180B022A-1A24-47AF-8D1E-9D881A7085B1Q47759449-68283B46-C029-40B9-A932-918A51E8ECDEQ47789434-83173D73-910F-4570-BFAE-065EE811608EQ48397754-F709C5F7-5A3A-4F8D-8888-FD96D7880682Q49324255-FA3B3FD2-0AC8-45B0-974C-837D9FCEA6FAQ49942492-D67A2C82-BF25-477F-AAA5-B0C14B229386Q50898286-437B48DD-E177-4796-AA24-9D8AEB9A71EFQ51005871-DBA7BCF2-8CF1-4E3B-A752-23A9D86DA439Q52148846-41EF02CB-5E8B-4097-8DAC-EA49AE5B9613Q53065710-153BB705-990A-437F-865F-E467D713C541Q53067649-A15C0C6E-CE0F-4C89-9EE0-FD3732F274D8Q58572579-59F70215-D1A2-48EC-90C1-EFA6411EFC54
P2860
Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Specificity and sensitivity of ...... cohort study in 196 patients.
@ast
Specificity and sensitivity of ...... cohort study in 196 patients.
@en
type
label
Specificity and sensitivity of ...... cohort study in 196 patients.
@ast
Specificity and sensitivity of ...... cohort study in 196 patients.
@en
prefLabel
Specificity and sensitivity of ...... cohort study in 196 patients.
@ast
Specificity and sensitivity of ...... cohort study in 196 patients.
@en
P2093
P2860
P1433
P1476
Specificity and sensitivity of ...... cohort study in 196 patients.
@en
P2093
Alfons Kessels
Angela E P Bouwmans
Annemarie M M Vlaar
Werner H Mess
Wim E J Weber
P2860
P356
10.1136/BMJOPEN-2013-002613
P577
2013-04-02T00:00:00Z